WC
OME

Wynnefield Capital’s Omega Protein OME Stock Holding History

Wynnefield Capital’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-265,108
Closed -$4.41M – 39
2017
Q3 		$4.41M Buy
265,108
+185,108
+231% +$3.01M 1.58% 19
2017
Q2 		$1.43M Hold
80,000
– – 0.48% 30
2017
Q1 		$1.6M Sell
80,000
-20,000
-20% -$466K 0.59% 28
2016
Q4 		$2.5M Sell
100,000
-342,971
-77% -$8.1M 0.9% 21
2016
Q3 		$10.4M Sell
442,971
-1,324,351
-75% -$31.1M 3.46% 11
2016
Q2 		$35.3M Buy
1,767,322
+24,686
+1% +$461K 12.79% 1
2016
Q1 		$29.5M Buy
1,742,636
+252,142
+17% +$5.17M 11.59% 1
2015
Q4 		$33.1M Sell
1,490,494
-197,423
-12% -$4.11M 11.18% 2
2015
Q3 		$28.6M Buy
1,687,917
+305,237
+22% +$4.75M 11.47% 3
2015
Q2 		$19M Buy
1,382,680
+447,680
+48% +$5.95M 7.32% 4
2015
Q1 		$12.8M Sell
935,000
-90,000
-9% -$1.04M 5.66% 7
2014
Q4 		$10.8M Buy
+1,025,000
New +$12.1M 4.56% 8

Wynnefield Capital's OME Position: Q4 2017 in Review

Wynnefield Capital sold out of Omega Protein (OME) in Q4 2017, closing a stake of 265,108 shares — an estimated $4.41M sold.

Wynnefield Capital first reported a position in OME in Q4 2014 and held it in 12 quarters. The position peaked at $35.3M in Q2 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

  • Wynnefield Capital reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
  • Wynnefield Capital sold 265,108 Omega Protein shares in Q4 2017, an estimated $4.41M.
  • Wynnefield Capital first reported a position in Omega Protein in Q4 2014 and held it in 12 quarters.
  • Wynnefield Capital's Omega Protein position peaked at $35.3M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Wynnefield Capital's 13F filing for Q4 2017, filed 14 Feb 2018.